Item | Considered relevant No. (% of reports) |
---|---|
Severe disease | 35 (76%) |
Value to caregivers | 14 (30%) |
Insurance value | 0 (0%) |
Scientific spillovers | 4 (9%) |
Lack of alternatives | 28 (61%) |
Substantial improvement in life expectancy | 29 (63%) |
Discounting | 23 (50%) |
Different discount rates employed | 18 (39%) |
Uncertainty | 40 (87%) |
Alternative payment models explored | 21 (46%) |